ESSA Pharma Inc. (EPIX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-10-09

ESSA Pharma Inc. (EPIX) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every EPIX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ESSA Pharma Inc. (EPIX)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001633932

Recent EPIX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-10-09	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	6.19M	—	—	SEC
2025-10-09	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	4.73M	—	—	SEC
2025-10-09	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	560.8K	—	—	SEC
2025-10-09	BERGER FRANKLIN M	Director	D — Derivative transaction	784.4K	—	—	SEC
2025-10-09	Parkinson David Ross	President and CEO	D — Derivative transaction	65.7K	—	—	SEC
2025-10-09	Glickman Richard M	Director	D — Derivative transaction	43.2K	—	—	SEC
2025-10-09	Martin John Alexander	Director	D — Derivative transaction	14.3K	—	—	SEC
2025-10-09	Requadt Scott	Director	D — Derivative transaction	30.0K	—	—	SEC
2025-10-09	Thorell Marella	Director	D — Derivative transaction	2.9K	—	—	SEC
2025-10-09	Wood David S.	Chief Financial Officer	D — Derivative transaction	33.3K	—	—	SEC
2025-08-05	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	1.48M	$0.00	$148	SEC
2025-08-05	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	1.24M	$0.00	$124	SEC
2025-08-05	BVF PARTNERS L P/IL	10% Owner	J — Other acquisition / disposition	203.3K	$0.00	$20	SEC
2025-08-05	BVF PARTNERS L P/IL	10% Owner	S — Open-market sale	79	$1.88	$148	SEC
2025-08-05	BVF PARTNERS L P/IL	10% Owner	S — Open-market sale	66	$1.88	$124	SEC

All transactions sourced from SEC EDGAR Form 4 filings for ESSA Pharma Inc. (EPIX). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-10-09 — BERGER FRANKLIN M (Director)
2025-10-09 — Parkinson David Ross (President and CEO)
2025-10-09 — Glickman Richard M (Director)
2025-10-09 — Martin John Alexander (Director)
2025-10-09 — BVF PARTNERS L P/IL (10% Owner)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EPIX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

EPIX Insider Trading — FAQ

What is the latest insider trade for EPIX?: ESSA Pharma Inc. (EPIX) had 0 insider filings in the last 90 days, with the most recent on 2025-10-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying EPIX stock?: 0 insider purchases of EPIX were filed in the last 90 days.
How many insiders are selling EPIX stock?: 0 insider sales of EPIX were filed in the last 90 days.
Where can I see EPIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every EPIX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live EPIX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.